- Home
- MREO vs MITT Comparison
MREO vs MITT Comparison
Compare MREO & MITT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MREO | MITT |
|---|---|---|
| Founded | 2015 | 2011 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 324.6M | 287.6M |
| IPO Year | N/A | 2011 |
Fundamental Metrics
Financial Performance| Metric | MREO | MITT |
|---|---|---|
| Price | $0.46 | $8.59 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 6 |
| Target Price | $3.90 | ★ $9.04 |
| AVG Volume (30 Days) | ★ 21.9M | 188.0K |
| Earning Date | 11-10-2025 | 03-02-2026 |
| Dividend Yield | N/A | ★ 10.70% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.94 |
| Revenue | $500,000.00 | ★ $87,678,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6,363.05 | $16.68 |
| P/E Ratio | ★ N/A | $9.16 |
| Revenue Growth | N/A | ★ 8.59 |
| 52 Week Low | $0.20 | $5.63 |
| 52 Week High | $3.26 | $9.27 |
Technical Indicators
Market Signals| Indicator | MREO | MITT |
|---|---|---|
| Relative Strength Index (RSI) | 31.93 | 44.75 |
| Support Level | $0.42 | $8.67 |
| Resistance Level | $0.78 | $8.99 |
| Average True Range (ATR) | 0.08 | 0.25 |
| MACD | 0.04 | -0.04 |
| Stochastic Oscillator | 10.72 | 4.81 |
Price Performance
Historical ComparisonAbout MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About MITT AG Mortgage Investment Trust Inc.
TPG Mortgage Investment Trust Inc is a real estate investment trust (REIT). It focuses on investing in a diversified risk-adjusted portfolio of residential mortgage-related assets in the U.S. mortgage market. Its objective is to provide attractive risk-adjusted returns to its stockholders over the long term through dividends and capital appreciation.